CA2441327A1 - Compositions proteiques humaines riches en arginine- - Google Patents
Compositions proteiques humaines riches en arginine- Download PDFInfo
- Publication number
- CA2441327A1 CA2441327A1 CA002441327A CA2441327A CA2441327A1 CA 2441327 A1 CA2441327 A1 CA 2441327A1 CA 002441327 A CA002441327 A CA 002441327A CA 2441327 A CA2441327 A CA 2441327A CA 2441327 A1 CA2441327 A1 CA 2441327A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- arpr
- polypeptide
- sequence
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne des compositions protéiques riches en arginine, y compris des polypeptides, des polynucléotides, et des anticorps. Ces composés sont utiles pour déceler et/ou surveiller les états liés à la croissance aberrante ou incontrôlée de tissus (par exemple, cancer).
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28067301P | 2001-03-30 | 2001-03-30 | |
US60/280,673 | 2001-03-30 | ||
US29345301P | 2001-05-24 | 2001-05-24 | |
US60/293,453 | 2001-05-24 | ||
PCT/EP2002/003395 WO2002079246A2 (fr) | 2001-03-30 | 2002-03-26 | Compositions proteiques humaines riches en arginine- |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2441327A1 true CA2441327A1 (fr) | 2002-10-10 |
Family
ID=26960444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002441327A Abandoned CA2441327A1 (fr) | 2001-03-30 | 2002-03-26 | Compositions proteiques humaines riches en arginine- |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1373314A2 (fr) |
CA (1) | CA2441327A1 (fr) |
WO (1) | WO2002079246A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002074956A2 (fr) * | 2001-03-20 | 2002-09-26 | Prescient Neuropharma Inc. | Facteurs promoteurs de la survie des neurones dopaminergiques et utilisations associes |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
EP2289908B1 (fr) * | 2003-07-11 | 2013-08-07 | Evotec International GmbH | Utilisation de produits des protéines DG177 sécretées pour la prévention et le traitement de maladies du pancreas et/ou de l'obésité et/ou du syndrome métabolique |
DK1969003T3 (da) * | 2005-12-14 | 2010-12-13 | Hermo Pharma Ltd | Anvendelser af et neurotrofisk faktor-protein |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
FI20080326A0 (fi) | 2008-04-30 | 2008-04-30 | Licentia Oy | Neurotroofinen tekijä MANF ja sen käytöt |
PL3246044T5 (pl) | 2010-08-23 | 2024-06-17 | Wyeth Llc | Stabilne preparaty antygenów rLP2086 Neisseria meningitidis |
ES2728282T3 (es) | 2010-09-10 | 2019-10-23 | Wyeth Llc | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis |
FI20115870A0 (fi) * | 2011-09-05 | 2011-09-05 | Urmas Arumaee | Neuroprotektiiviset soluihin tunkeutuvat peptidit |
RU2665841C2 (ru) | 2012-03-09 | 2018-09-04 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их применения |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
CA2903716C (fr) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Polypeptides immunogenes de fusion |
RU2662968C2 (ru) | 2013-09-08 | 2018-07-31 | Пфайзер Инк. | Иммуногенная композиция против neisseria meningitidis (варианты) |
WO2015200469A1 (fr) * | 2014-06-24 | 2015-12-30 | University Of Massachusetts | Manf en tant que régulateur du fonctionnement du système immunitaire |
US20170252403A1 (en) * | 2014-10-06 | 2017-09-07 | Amarantus Bioscience Holdings, Inc. | Methods and compositions for treating retinal disorders |
RU2723045C2 (ru) | 2015-02-19 | 2020-06-08 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их получения |
PE20191107A1 (es) | 2017-01-31 | 2019-08-26 | Pfizer | Composiciones de neisseria meningitidis y metodos respectivos |
CA3062241A1 (fr) * | 2017-05-04 | 2018-11-08 | Helsingin Yliopisto | Fragments cdnf et manf c-terminaux, compositions pharmaceutiques les comprenant et leurs utilisations |
-
2002
- 2002-03-26 CA CA002441327A patent/CA2441327A1/fr not_active Abandoned
- 2002-03-26 WO PCT/EP2002/003395 patent/WO2002079246A2/fr not_active Application Discontinuation
- 2002-03-26 EP EP02722272A patent/EP1373314A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002079246A3 (fr) | 2002-12-12 |
WO2002079246A2 (fr) | 2002-10-10 |
EP1373314A2 (fr) | 2004-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2441327A1 (fr) | Compositions proteiques humaines riches en arginine- | |
JP4234319B2 (ja) | 前立腺腫瘍ポリヌクレオチドおよび抗原組成物 | |
JP2002502589A (ja) | 45個のヒト分泌タンパク質 | |
JP2002521055A (ja) | 98個のヒト分泌タンパク質 | |
US20030204071A1 (en) | 109 human secreted proteins | |
JP2002533058A (ja) | 97個のヒト分泌タンパク質 | |
JP2002526073A (ja) | 新規のヒト生長分化因子のコード配列、そのdna配列によりコードされるポリペプチド、およびこれらの製造方法。 | |
JP2002532083A (ja) | 47個のヒト分泌タンパク質 | |
JP2002506627A (ja) | 95個のヒト分泌タンパク質 | |
JP2002506625A (ja) | サイトカインレセプター共通γ鎖様 | |
JP2002526059A (ja) | 31個のヒト分泌タンパク質 | |
JP2003525566A (ja) | 125個のヒト分泌タンパク質 | |
JP2003524366A (ja) | 64個のヒト分泌タンパク質 | |
JP2002505871A (ja) | 31個のヒト分泌タンパク質 | |
JP2002541833A (ja) | 49個のヒト分泌タンパク質 | |
JP2001519179A (ja) | 53個のヒト分泌タンパク質 | |
JP2002532054A (ja) | 29個のヒト分泌タンパク質 | |
JP2003528586A (ja) | 32個のヒト分泌タンパク質 | |
US20040171825A1 (en) | Human fibroblast growth factor-related compositions | |
JP2001519156A (ja) | 101個のヒト分泌タンパク質 | |
JP2002504361A (ja) | 36個のヒト分泌タンパク質 | |
JP2003520030A (ja) | 28個のヒト分泌タンパク質 | |
AU2002253165A1 (en) | Human arginine-rich protein-related compositions | |
JP2002502601A (ja) | 樹状富化分泌リンパ球活性化分子 | |
EP1602726A2 (fr) | Variants d'épissage associés à la tachykinine humaine et compositions les comprenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |